Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Getting to know SQI Diagnostics....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(494)
•••
Comment by FactFinder1994on Mar 17, 2021 10:45am
107 Views
Post# 32815992

RE:Getting to know SQI Diagnostics....

RE:Getting to know SQI Diagnostics....I encourage those interested to watch and listen to the entire video closely and then review the most recent investor presentation.  The dots aren't overly difficult to connect if you have sufficient background.  For anyone that wants to be spoon fed, this isn't the stock for you.  
Get to understand the phases of this pandemic and how it will progress/change over time.  
Speak with and/or follow KOL's who are dialed in.    
Also - look way beyond Covid-19 to fully grasp the magnitude of the opportunities SQI has before them.  You may be shocked at how productive a little digging can be....
For those that don't have the time or aptitude to decipher details, that's ok....this stock isn't for you, and that is with no intended offence to anyone.   This remains a near private story and only after significant success will it then be obvious to others.  
Stay tuned if interested,            
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities